CD8A and cancer: Furthermore, control β.anti-NKG2A without IL-15 stimulated degranulation of NK cells with additional IFN-γ expression on CD8+ T cells as well, indicating that blocking the receptor in the context of viral infection might be more effective than in the context of cancer therapy.